Science
Eli Lilly on Track to Become First $1 Trillion Health-Care Giant Thanks to Breakthrough Treatments
Exciting times are on the horizon for Eli Lilly as the pharmaceutical powerhouse edges closer to becoming the first health-care...
Uber Introduces New Features to Promote Sustainability, Including All-Electric Ride Option and AI Chatbot for Drivers
Bitcoin Plunges to Nearly $60,000 as Middle Eastern Tensions Shake Global Markets
Amazon Introduces AI Assistant Amelia to Empower Third-Party Sellers
The Hidden Dangers of Bitcoin ATMs: A Growing Cybercrime Threat
Federal Judge Clears Path for X’s Lawsuit Against Media Matters to Proceed to Trial
OpenAI Closes Funding Round at $157 Billion Valuation with Backing from Microsoft, Nvidia, and SoftBank
Apple Unveils iPhone 16 Lineup at ‘It’s Glowtime’ Event
Qualcomm Collaborates with Samsung and Google on Innovative Mixed Reality Smart Glasses
Nokia Launches $130 Barbie Phone Without Internet Access
Review: Motorola Razr+ and Razr (2024)
Earth Officially Captures a Second Moon — Say Hello to Asteroid 2024 PT5
Roche’s Ambitious Move into Weight Loss Drug Market Faces Challenges Amid Competitor Dominance
Eli Lilly on Track to Become First $1 Trillion Health-Care Giant Thanks to Breakthrough Treatments
WHO Declares Mpox a Global Health Emergency Amid Rising Cases
Health Experts Sound Alarm Over Latest Mpox Outbreak
Exciting times are on the horizon for Eli Lilly as the pharmaceutical powerhouse edges closer to becoming the first health-care...
Eli Lilly is gaining a competitive edge over Novo Nordisk in the rapidly growing market for GLP-1 weight loss and...
Eli Lilly’s groundbreaking weight loss drug, Zepbound, has demonstrated significant benefits in patients suffering from a common type of heart...
